These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31670491)
1. Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation. Giordano A; Corcione N; Ferraro P; Morello A; Conte S; Testa L; Iadanza A; Sardella G; Mancone M; Berti S; Petronio AS; Romagnoli E; Pepe M; Frati G; Biondi-Zoccai G; Minerva Cardioangiol; 2019 Dec; 67(6):443-449. PubMed ID: 31670491 [TBL] [Abstract][Full Text] [Related]
2. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation. Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J Int J Cardiol; 2016 Nov; 223():564-567. PubMed ID: 27561160 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of ProGlide Versus Prostar XL Vascular Closure Devices in Transcatheter Aortic Valve Replacement: The RISPEVA Registry. Berti S; Bedogni F; Giordano A; Petronio AS; Iadanza A; Bartorelli AL; Reimers B; Spaccarotella C; Trani C; Attisano T; Marella Cenname A; Sardella G; Bonmassari R; Medda M; Tomai F; Tarantini G; Navarese EP; J Am Heart Assoc; 2020 Nov; 9(21):e018042. PubMed ID: 33103545 [TBL] [Abstract][Full Text] [Related]
4. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation. Barbash IM; Barbanti M; Webb J; Molina-Martin De Nicolas J; Abramowitz Y; Latib A; Nguyen C; Deuschl F; Segev A; Sideris K; Buccheri S; Simonato M; Rosa FD; Tamburino C; Jilaihawi H; Miyazaki T; Himbert D; Schofer N; Guetta V; Bleiziffer S; Tchetche D; Immè S; Makkar RR; Vahanian A; Treede H; Lange R; Colombo A; Dvir D Eur Heart J; 2015 Dec; 36(47):3370-9. PubMed ID: 26314688 [TBL] [Abstract][Full Text] [Related]
6. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation. Mehilli J; Jochheim D; Abdel-Wahab M; Rizas KD; Theiss H; Spenkuch N; Zadrozny M; Baquet M; El-Mawardy M; Sato T; Lange P; Kuppatt C; Greif M; Hausleiter J; Bauer A; Schwarz F; Pichlmaier M; Hagl C; Richardt G; Massberg S EuroIntervention; 2016 Nov; 12(10):1298-1304. PubMed ID: 27866140 [TBL] [Abstract][Full Text] [Related]
7. Impact of closure devices on vascular complication and mortality rates in TAVI procedures. Dimitriadis Z; Scholtz W; Börgermann J; Wiemer M; Piper C; Vlachojannis M; Gummert J; Horstkotte D; Ensminger S; Faber L; Scholtz S Int J Cardiol; 2017 Aug; 241():133-137. PubMed ID: 28153535 [TBL] [Abstract][Full Text] [Related]
8. A systematic review on the safety of Prostar XL versus ProGlide after TAVR and EVAR. Maniotis C; Andreou C; Karalis I; Koutouzi G; Agelaki M; Koutouzis M Cardiovasc Revasc Med; 2017 Mar; 18(2):145-150. PubMed ID: 27887905 [TBL] [Abstract][Full Text] [Related]
9. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry. Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881 [TBL] [Abstract][Full Text] [Related]
10. Vascular complications of ProGlide versus Prostar in transcatheter aortic valve replacement (TAVR) procedures: meta-analysis. Xiang Y; Chen C; Zhao J; Ma Y; Huang B; Wu Z BJS Open; 2023 Jul; 7(4):. PubMed ID: 37498966 [TBL] [Abstract][Full Text] [Related]
12. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure. Saleh N; De Palma R; Settergren M; Rück A Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528 [TBL] [Abstract][Full Text] [Related]
13. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation. Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978 [TBL] [Abstract][Full Text] [Related]
14. Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. Barbanti M; Capranzano P; Ohno Y; Gulino S; Sgroi C; Immè S; Tamburino C; Cannata S; Patanè M; Di Stefano D; Todaro D; Di Simone E; Deste W; Gargiulo G; Capodanno D; Grasso C; Tamburino C EuroIntervention; 2015 Oct; 11(6):690-7. PubMed ID: 26499222 [TBL] [Abstract][Full Text] [Related]
15. Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis. Sedhom R; Dang AT; Elwagdy A; Megaly M; Elgendy IY; Zahr F; Gafoor S; Mamas M; Elbadawi A Catheter Cardiovasc Interv; 2023 Mar; 101(4):817-827. PubMed ID: 36802100 [TBL] [Abstract][Full Text] [Related]
16. Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTA. Gheorghe L; Brouwer J; Mathijssen H; Nijenhuis VJ; Rensing BJ; Swaans MJ; Chan Pin Yin DR; Heijmen RH; De Kroon T; Sonker U; Van der Heyden JA; Ten Berg JM Am J Cardiol; 2019 Oct; 124(8):1265-1271. PubMed ID: 31443900 [TBL] [Abstract][Full Text] [Related]
17. Manta versus Perclose ProGlide vascular closure device after transcatheter aortic valve implantation: Initial experience from a large European center. Dumpies O; Kitamura M; Majunke N; Hartung P; Haag A; Wilde J; Desch S; Sandri M; Crusius L; Noack T; Kiefer P; Leontyev S; Borger M; Thiele H; Holzhey D; Abdel-Wahab M Cardiovasc Revasc Med; 2022 Apr; 37():34-40. PubMed ID: 34257057 [TBL] [Abstract][Full Text] [Related]
18. MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation. Biancari F; Romppanen H; Savontaus M; Siljander A; Mäkikallio T; Piira OP; Piuhola J; Vilkki V; Ylitalo A; Vasankari T; Airaksinen JKE; Niemelä M Int J Cardiol; 2018 Jul; 263():29-31. PubMed ID: 29681408 [TBL] [Abstract][Full Text] [Related]
19. Ultrasound-guided deployment of ProGlide™ device in transfemoral transcatheter aortic valve implantation and risk reduction of vascular complications: A propensity-matched cohort study. Ross DS; Nogic J; Cong H; Nuzzi V; Thanikachalam P; Veenuraju S; Gruner-Hegge N; Anwar M; O'Sullivan M; Costopoulos C; Davies WR; Costanzo P Catheter Cardiovasc Interv; 2024 Apr; 103(5):771-781. PubMed ID: 38451155 [TBL] [Abstract][Full Text] [Related]
20. Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation. Giordano A; Corcione N; Ferraro P; Morello A; Conte S; Testa L; Bedogni F; Iadanza A; Berti S; Regazzoli D; Romagnoli E; Trani C; Burzotta F; Pepe M; Frati G; Biondi-Zoccai G; Sci Rep; 2019 Nov; 9(1):17098. PubMed ID: 31745198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]